Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05986578 · ClinicalTrials.gov registry record · NA

Identifying Electrophysiological Targets for Transcranial Magnetic Stimulation in Cocaine Use Disorder

A NA study of Cocaine Use Disorder, sponsored by The University of Texas Health Science Center, Houston.

Recruiting
Registry status
NA
Development phase
75
Enrollment target
1
Study location

NCT05986578 is a NA study of Cocaine Use Disorder that is actively recruiting participants, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 75 participants, below the 101-participant average among 26 other Cocaine Use Disorder trials with a reported enrollment target (26% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05986578, a NA study of Cocaine Use Disorder, is actively recruiting participants, sponsored by The University of Texas Health Science Center, Houston.

RECRUITING
Registry status
NA
Development phase
75 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to assess effects of intermittent theta burst stimulation (iTBS) to left dorsolateral prefrontal cortex (dlPFC) and dorsomedial prefrontal cortex (dmPFC) compared to sham on electrophysiological indices of reward sensitivity and motivated attention in adults with cocaine use disorder.

Conditions Studied

Interventions

  • DEVICE TMS to dmPFC
  • DEVICE TMS to dlPFC
  • DEVICE Sham iTBS

Study Locations (1)

Texas

  • The University of Texas Health Science Center at Houston - Houston

Trial Details

FieldValue
Enrollment Target 75 participants
Start Date 2024-11-08
Est. Completion 2028-06-30
Phase NA

What the Registry Record Tells You About NCT05986578

The ClinicalTrials.gov registry entry for NCT05986578 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 101-participant average among 26 other Cocaine Use Disorder trials with a reported enrollment target (26% lower). The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cocaine Use Disorder appearing as the primary indexed condition, and to 3 interventions - of which TMS to dmPFC is the first listed.

NCT05986578 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT05986578 about?

NCT05986578 is a clinical study titled "Identifying Electrophysiological Targets for Transcranial Magnetic Stimulation in Cocaine Use Disorder". The purpose of this study is to assess effects of intermittent theta burst stimulation (iTBS) to left dorsolateral prefrontal cortex (dlPFC) and dorsomedial prefrontal cortex (dmPFC) compared to sham on electrophysiological indices of reward sensitivity and motivated attention in adults with cocaine...

What is the current status of trial NCT05986578?

This trial is currently recruiting. It is a NA study. The enrollment target is 75 participants. The study started on 2024-11-08. Estimated completion is 2028-06-30.

What conditions does trial NCT05986578 study?

This clinical trial studies the following conditions: Cocaine Use Disorder.

What interventions are being tested in trial NCT05986578?

The interventions under investigation include: TMS to dmPFC (DEVICE), TMS to dlPFC (DEVICE), Sham iTBS (DEVICE).

Who is sponsoring clinical trial NCT05986578?

This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05986578 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cocaine Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.